SB5 shows cross-immunogenicity to adalimumab but not infliximab: results in patients with inflammatory bowel disease or rheumatoid arthritis
Goncalves, Joao, Myung, Gihyun, Park, MinJeong, Jeong, Deokyoon, Ghil, Jeehoon
Published in Therapeutic advances in gastroenterology (2019)
Published in Therapeutic advances in gastroenterology (2019)
Get full text
Journal Article
A Randomized, Double-Blind, Single-Dose Phase 1 Comparative Pharmacokinetic Study Comparing SB12 (Eculizumab Biosimilar) with Reference Eculizumab in Healthy Volunteers
Lee, Hyun A, Jang, Hyerin, Kim, Yeonsoo, Jeong, Deokyoon, Lee, Jieun, Jung, Jin Ah, Demichelis, Roberta
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
A randomized, double-blind, three-arm, parallel group, single-dose phase I study to evaluate the pharmacokinetic similarity between SB12 (a proposed eculizumab biosimilar) and eculizumab (Soliris) in healthy subjects
Lee, Hyun A, Jang, Hyerin, Jeong, Deokyoon, Kim, Younsoo, Fuhr, Rainard
Published in International journal of clinical pharmacology and therapeutics (01.06.2022)
Published in International journal of clinical pharmacology and therapeutics (01.06.2022)
Get full text
Journal Article